bronchial asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with poorly controlled asthma (ACT score <20) undergoing outpatient treatment who use an asthma management app during the period from January 1, 2026, to December 31, 2026. 2. Patients aged 18 years or older. 3. Patients who can provide informed consent to participate in the trial of their own free will.
Exclusion criteria
Exclusion criteria: 1. Patients who declined to participate in this study 2. Patients deemed unsuitable for this study by the principal investigator 3. Patients participating in other clinical trials of drugs or medical devices
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in ACT Scores: Average change in ACT scores from the start of app use to 6 months later | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of asthma exacerbations over 6 months Frequency of oral steroid rescue medication use over 6 months Change in AHQ-33 JAPAN score over 6 months Change in adherence rate for regular inhaled and oral medications based on app records Frequency of emergency/out-of-hours outpatient visits and hospitalizations: Number of emergency/out-of-hours outpatient visits and hospitalizations over 6 months Change in maintenance oral steroid dosage over 6 months Frequency of asthma exacerbations over 6 months Frequency of oral steroid rescue medication use over 6 months Change in AHQ-33 JAPAN score over 6 months Change in adherence rate to regular inhaled and oral medications based on app records Frequency of emergency/after-hours outpatient visits and hospitalizations: Number of emergency/after-hours outpatient visits and hospitalizations over 6 months Change in maintenance oral steroid dosage over 6 months | — |
Countries
Japan
Contacts
Social Medical Foundation Society of St. Francis Himeji St. Mary's Hospital Respiratory Medicine